Logo image of BAM

BROOKFIELD ASSET MGMT-A (BAM) Stock Fundamental Analysis

NYSE:BAM - New York Stock Exchange, Inc. - CA1130041058 - Common Stock - Currency: USD

48.59  +0.6 (+1.25%)

After market: 48.5 -0.09 (-0.19%)

Fundamental Rating

4

Taking everything into account, BAM scores 4 out of 10 in our fundamental rating. BAM was compared to 227 industry peers in the Capital Markets industry. BAM has an average financial health and profitability rating. BAM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BAM had positive earnings in the past year.
BAM had a positive operating cash flow in the past year.
Of the past 5 years BAM 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: BAM reported negative operating cash flow in multiple years.
BAM Yearly Net Income VS EBIT VS OCF VS FCFBAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

1.2 Ratios

BAM has a better Return On Assets (10.41%) than 88.55% of its industry peers.
With a decent Return On Equity value of 13.99%, BAM is doing good in the industry, outperforming 69.60% of the companies in the same industry.
The Return On Invested Capital of BAM (1.55%) is worse than 67.40% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BAM is below the industry average of 7.06%.
Industry RankSector Rank
ROA 10.41%
ROE 13.99%
ROIC 1.55%
ROA(3y)7.32%
ROA(5y)4.86%
ROE(3y)13.82%
ROE(5y)10.26%
ROIC(3y)3.33%
ROIC(5y)N/A
BAM Yearly ROA, ROE, ROICBAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

BAM has a better Profit Margin (86.21%) than 96.92% of its industry peers.
BAM's Profit Margin has improved in the last couple of years.
BAM has a worse Operating Margin (13.03%) than 68.72% of its industry peers.
In the last couple of years the Operating Margin of BAM has declined.
Industry RankSector Rank
OM 13.03%
PM (TTM) 86.21%
GM N/A
OM growth 3Y-40.15%
OM growth 5Y-3.5%
PM growth 3Y85.4%
PM growth 5Y79.53%
GM growth 3YN/A
GM growth 5YN/A
BAM Yearly Profit, Operating, Gross MarginsBAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 200 400 600 800 1K

6

2. Health

2.1 Basic Checks

There is no outstanding debt for BAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BAM Yearly Shares OutstandingBAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
BAM Yearly Total Debt VS Total AssetsBAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100B 200B 300B

2.2 Solvency

An Altman-Z score of 43.21 indicates that BAM is not in any danger for bankruptcy at the moment.
BAM's Altman-Z score of 43.21 is amongst the best of the industry. BAM outperforms 99.12% of its industry peers.
BAM has a debt to FCF ratio of 0.39. This is a very positive value and a sign of high solvency as it would only need 0.39 years to pay back of all of its debts.
BAM has a Debt to FCF ratio of 0.39. This is amongst the best in the industry. BAM outperforms 89.87% of its industry peers.
BAM has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
BAM's Debt to Equity ratio of 0.07 is amongst the best of the industry. BAM outperforms 81.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.39
Altman-Z 43.21
ROIC/WACCN/A
WACCN/A
BAM Yearly LT Debt VS Equity VS FCFBAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50B 100B

2.3 Liquidity

BAM has a Current Ratio of 0.87. This is a bad value and indicates that BAM is not financially healthy enough and could expect problems in meeting its short term obligations.
BAM has a Current ratio (0.87) which is comparable to the rest of the industry.
BAM has a Quick Ratio of 0.87. This is a bad value and indicates that BAM is not financially healthy enough and could expect problems in meeting its short term obligations.
BAM has a Quick ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
BAM Yearly Current Assets VS Current LiabilitesBAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2B 4B 6B

3

3. Growth

3.1 Past

BAM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.84%.
Measured over the past years, BAM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.34% on average per year.
EPS 1Y (TTM)5.84%
EPS 3Y-15.34%
EPS 5YN/A
EPS Q2Q%11.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.89%

3.2 Future

The Earnings Per Share is expected to grow by 16.55% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.17% on average over the next years. This is quite good.
EPS Next Y16.24%
EPS Next 2Y16.81%
EPS Next 3Y16.55%
EPS Next 5YN/A
Revenue Next Year12.5%
Revenue Next 2Y13.73%
Revenue Next 3Y13.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
BAM Yearly Revenue VS EstimatesBAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BAM Yearly EPS VS EstimatesBAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.51 indicates a quite expensive valuation of BAM.
Based on the Price/Earnings ratio, BAM is valued a bit more expensive than the industry average as 73.57% of the companies are valued more cheaply.
BAM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 28.83, which means the current valuation is very expensive for BAM.
Based on the Price/Forward Earnings ratio, BAM is valued a bit more expensive than 71.37% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BAM to the average of the S&P500 Index (21.08), we can say BAM is valued slightly more expensively.
Industry RankSector Rank
PE 33.51
Fwd PE 28.83
BAM Price Earnings VS Forward Price EarningsBAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAM indicates a somewhat cheap valuation: BAM is cheaper than 60.79% of the companies listed in the same industry.
BAM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 143.34
EV/EBITDA 970
BAM Per share dataBAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as BAM's earnings are expected to grow with 16.55% in the coming years.
PEG (NY)2.06
PEG (5Y)N/A
EPS Next 2Y16.81%
EPS Next 3Y16.55%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.72%, BAM has a reasonable but not impressive dividend return.
BAM's Dividend Yield is comparable with the industry average which is at 8.84.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.57.
Industry RankSector Rank
Dividend Yield 2.72%

5.2 History

BAM has been paying a dividend for at least 10 years, so it has a reliable track record.
BAM has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years6
Div Non Decr Years6
BAM Yearly Dividends per shareBAM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BAM pays out 132.44% of its income as dividend. This is not a sustainable payout ratio.
DP132.44%
EPS Next 2Y16.81%
EPS Next 3Y16.55%
BAM Yearly Income VS Free CF VS DividendBAM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
BAM Dividend Payout.BAM Dividend Payout, showing the Payout Ratio.BAM Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

NYSE:BAM (4/17/2025, 8:04:00 PM)

After market: 48.5 -0.09 (-0.19%)

48.59

+0.6 (+1.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners17.29%
Inst Owner Change0%
Ins Owners1.96%
Ins Owner ChangeN/A
Market Cap79.56B
Analysts66.67
Price Target60.17 (23.83%)
Short Float %3.58%
Short Ratio7.95
Dividend
Industry RankSector Rank
Dividend Yield 2.72%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP132.44%
Div Incr Years6
Div Non Decr Years6
Ex-Date02-28 2025-02-28 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.59%
Min EPS beat(2)-2.55%
Max EPS beat(2)5.74%
EPS beat(4)2
Avg EPS beat(4)1.27%
Min EPS beat(4)-3.62%
Max EPS beat(4)5.74%
EPS beat(8)5
Avg EPS beat(8)2.44%
EPS beat(12)8
Avg EPS beat(12)22.85%
EPS beat(16)10
Avg EPS beat(16)68.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.58%
Revenue beat(4)0
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)-0.36%
Revenue beat(8)1
Avg Revenue beat(8)-5.24%
Revenue beat(12)2
Avg Revenue beat(12)-3.4%
Revenue beat(16)4
Avg Revenue beat(16)122.29%
PT rev (1m)-0.67%
PT rev (3m)5.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 33.51
Fwd PE 28.83
P/S 152.41
P/FCF 143.34
P/OCF 133.93
P/B 24.73
P/tB 24.73
EV/EBITDA 970
EPS(TTM)1.45
EY2.98%
EPS(NY)1.69
Fwd EY3.47%
FCF(TTM)0.34
FCFY0.7%
OCF(TTM)0.36
OCFY0.75%
SpS0.32
BVpS1.96
TBVpS1.96
PEG (NY)2.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.41%
ROE 13.99%
ROCE 2.09%
ROIC 1.55%
ROICexc 1.56%
ROICexgc 1.59%
OM 13.03%
PM (TTM) 86.21%
GM N/A
FCFM 106.32%
ROA(3y)7.32%
ROA(5y)4.86%
ROE(3y)13.82%
ROE(5y)10.26%
ROIC(3y)3.33%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.39%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.15%
OM growth 5Y-3.5%
PM growth 3Y85.4%
PM growth 5Y79.53%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.39
Debt/EBITDA 2.66
Cap/Depr 278.57%
Cap/Sales 7.47%
Interest Coverage 4.25
Cash Conversion 724.39%
Profit Quality 123.33%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 43.21
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)237.01%
Cap/Depr(5y)202.68%
Cap/Sales(3y)15.66%
Cap/Sales(5y)9.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.84%
EPS 3Y-15.34%
EPS 5YN/A
EPS Q2Q%11.11%
EPS Next Y16.24%
EPS Next 2Y16.81%
EPS Next 3Y16.55%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.89%
Revenue Next Year12.5%
Revenue Next 2Y13.73%
Revenue Next 3Y13.17%
Revenue Next 5YN/A
EBIT growth 1Y-93.06%
EBIT growth 3Y-66.34%
EBIT growth 5Y-64.49%
EBIT Next Year4.69%
EBIT Next 3Y14.09%
EBIT Next 5Y15.1%
FCF growth 1Y-88.15%
FCF growth 3Y-35.81%
FCF growth 5Y-31.93%
OCF growth 1Y49.62%
OCF growth 3Y-34.24%
OCF growth 5Y-37.1%